Letter to the editor
Risk of ticagrelor versus clopidogrel discontinuation. Response

Riesgo de interrupción del ticagrelor frente al clopidogrel. Respuesta

Manuel Almendro-DeliaJuan C. García-RubiraRafael Hidalgo-Urbano

Rev Esp Cardiol. 2024;77:35610.1016/j.rec.2023.11.018

Manuel Martínez-Sellés

https://doi.org/10.1016/j.rec.2023.11.015

View PDF

Lea este artículo en español

Year/month	Html	Pdf	Total
2024 October	1	0	1
2024 September	50	0	50
2024 August	19	0	19
2024 June	1	0	1
2024 April	2	0	2
2024 March	4	0	4
2024 February	1	0	1
2024 January	359	2	361

Subscribe to the journal

By purchasing the article, the PDF of the same can be downloaded

Price: 19,34 €

Monday to Friday from 9am to 6pm (GMT+1) except for the months of July and August, which will be from 9am to 3pm

Calls from Spain 932 415 960

Calls from outside Spain +34 932 415 960

https://doi.org/10.1016/j.rec.2023.11.015

View PDF

Lea este artículo en español